Missing/wrong data?
Log in to edit
Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group
scientific article
Author/s
author: Howard Trachtman, Jeffrey B. Kopp, Virginia J Savin, Daniel C. Cattran, Debbie S Gipson
Work details
Publication date
November 22, 2009
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.